Volume 10 Supplement 1

2011 Pediatric Rheumatology Symposium: Abstracts

Open Access

Comparison of multiplex, ELISA and immunofluorescence for detecting autoantibodies in JIA patients

  • Paul T Fawcett1,
  • Victoria L Maduskuie1 and
  • Carlos D Rose1
Pediatric Rheumatology201210(Suppl 1):A117

https://doi.org/10.1186/1546-0096-10-S1-A117

Published: 13 July 2012

Purpose

Detection of antinuclear antibodies has traditionally been performed by immunofluorescence (IFA) on fixed culture cells or tissues with reactivity being reported as a fluorescence pattern associated to one or more nuclear antigens. For this study, we compared results from IFA testing with a multiplex antinuclear antibody assay on a panel of patient serum samples previously evaluated by 3 commercial ANA ELISAs.

Methods

Patient samples: Serum samples from 164 pediatric patients with JIA (82 pauciarticular, 63 polyarticular, 19 systemic) and 20 healthy children (autodonor samples) were tested according to manufacturer’s instructions for all methods. All specimens were stored at -80°C. Testing using 3 ANA ELISAs, IFA and multiplex were performed in batch to minimize freeze thaw cycles. IFA was performed on fixed HEp-2 cell substrate slides with fluorescence pattern and titer determined by an experienced medical technologist. ELISAs included the following antigen mixtures: Sm, RNP, SSA, SSB, Scl-70, JO-1, dsDNA, histones and centromere. The multiplex assay contained substrate beads for individual quantitative detection of antibodies to all of the antigens contained in the ELISAs and qualitative detection of ANA.

Results

See table 1.
Table 1

Evaluation of IFA, multiplex and ELISA antinuclear antibody testing in pediatric JIA patients

  

Number testing positive

  

IFA

Multiplex

ELISA

Types of JIA

# of Samples (n-184)

Hep-2

Microparticle

A.

B.

C.

Pauciarticular

82

62

27 *(3) + **(7)

4 + *(1)

32 + *(5)

52 + *(8)

Polyarticular

63

34

16 *(2) + **(1)

10 + *(4)

30 + *(14)

46 + *(21)

Systemic

19

3

5 + *(4)

1 + *(1)

6 + *(4)

12 + *(12)

All JIA with ≥ 1:160 IFA

164

52

22

   

Normals

20

6

1 + **(2)

0 + **(2)

4 + *(1)

5 + *(2)

Numbers in parentheses: * IFA Negative(s) that were Positive. **IFA Positives that were Equivocal

As previously reported, ELISA testing did not correlate with IFA results. Multiplex showed a similar discrepancy with IFA when assessed qualitatively: 48 multiplexed positive JIA versus 98 IFA positives. When higher titer IFA positives (≥ 1:160) were compared with multiplex, findings were similar: 22 multiplex positive versus 52 IFA positive.

Conclusion

Data obtained from this study indicates that neither ELISA nor multiplex testing, using individually quantifiable antigens, perform the same as IFA to screen pediatric patients with JIA. The lack of agreement between test methods may reflect differences in the array of antigens present in the various assays. Results suggest that both multiplex and ELISA can not replace IFA for routine screening in JIA. However, unlike the ELISAs, the multiplex assay has the advantage of allowing quantitative determination of autoantibodies to each individual nuclear antigen which makes it a superior choice for reflex testing for antibodies to individual nuclear antigens.

Disclosure

Paul T. Fawcett: None; Victoria L. Maduskuie: None; Carlos D. Rose: None.

Authors’ Affiliations

(1)
A I DuPont Hospital for Children

Copyright

© Fawcett et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement